Voluntary ex ante transparency notice: Reagents and antibodies for HLA-typing for Oslo University Hospital.
Oslo University Hospital intends to enter into a framework agreement for reagents and antibodies for HLA-typing at Oslo University Hospital.
Angebotsfrist:05. März 2026(abgelaufen)